Amanote Research
Register
Sign In
First-Line Drugs for Hypertension
Cochrane Database of Systematic Reviews
doi 10.1002/14651858.cd001841.pub3
Full Text
Open PDF
Abstract
Available in
full text
Date
April 18, 2018
Authors
James M Wright
Vijaya M Musini
Rupam Gill
Publisher
Wiley
Related search
Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Prevalence of Adverse Drug Reaction With First-Line Drugs Among Patients Treated for Pulmonary Tuberculosis
Clinical Epidemiology and Global Health
Epidemiology
Public Health
Microbiology
Environmental
Infectious Diseases
Occupational Health
Ablation Versus Drugs: What Is the Best First-Line Therapy for Paroxysmal Atrial Fibrillation?: Antiarrhythmic Drugs Are Outmoded and Catheter Ablation Should Be the First-Line Option for All Patients With Paroxysmal Atrial Fibrillation: Pro
Circulation: Arrhythmia and Electrophysiology
Medicine
Cardiovascular Medicine
Physiology
Cardiology
Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs
Journal of Clinical Microbiology
Microbiology
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation
JAMA - Journal of the American Medical Association
Medicine
First-Line Ibrutinib Confirmed for CLL
Cancer Discovery
Oncology
Nanoscaled Hydrated Antimony (V) Oxide as a New Approach to First-Line Antileishmanial Drugs
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
First-Line Atezolizumab OK'd for SCLC
Cancer Discovery
Oncology
Competency Requirements for First-Line Managers
SA Journal of Human Resource Management
Human Resource Management
Demography
Organizational Behavior
